多囊卵巢综合征与非多囊卵巢综合征女性的生育治疗路径及活产:一项回顾性人群关联数据研究
该回顾性全国社区队列研究纳入1,109名接受生育治疗的女性,其中25%患多囊卵巢综合征(PCOS)。PCOS女性更可能以促排卵(OI)起始(71% vs 36%,OR 4.20,95%CI 2.91-6.07),但总体活产率(63%)及校正后活产不因末次治疗类型或PCOS状态而异。
要点
- PCOS女性首次生育治疗平均年龄31.4岁,比非PCOS女性早3年。
- PCOS女性以OI起始的比例为71%,非PCOS女性为36%(OR 4.20,95%CI 2.91-6.07)。
- 校正后活产不因末次治疗类型或PCOS状态而异,35岁以下女性活产率74%。
核心结论
- 更多PCOS女性使用了生育治疗,但活产与非PCOS女性相当。
- 大多数女性遵循了临床推荐。
- 不同治疗路径间活产无差异,因此以创伤较小的治疗起始并无劣势(尽管可能存在经济或情感上的劣势)。
研究设计与样本
- 回顾性全国社区队列研究,使用1996-2022年自我报告调查数据(年龄18-49岁)及1996-2021年生育治疗关联行政数据。
- 研究对象为1973-1978年出生、参与澳大利亚妇女健康纵向研究的女性。
- 8,463名合格女性中,1,109名接受了生育治疗并纳入分析。
- PCOS诊断基于自我报告。
- 主要结局指标:通过关联行政数据确定促排卵(OI)、宫内人工授精和/或体外受精(IVF)的使用;活产为自我报告。
主要发现
- 合格参与者中1/10患PCOS(783/7,987,10%),接受生育治疗女性中1/4患PCOS(274/1,109,25%)。
- PCOS女性首次生育治疗平均年龄31.4岁(SD=4.18),非PCOS女性34.2岁(SD=4.56)。
- 共识别7种治疗路径,使用情况因PCOS状态而异;PCOS女性更可能以OI起始(71%;OR 4.20,95%CI 2.91-6.07),非PCOS女性为36%。
- 以OI起始的PCOS女性中,46%需要额外类型治疗;更多非PCOS女性最终接受IVF(72% vs 51%)。
- 总体63%(701/1,109)获得活产;校正回归中活产不因末次治疗类型而异(IVF:67%为参照;宫内人工授精:67%,OR 0.94,95%CI 0.56-1.58;OI:61%,OR 0.71,95%CI 0.52-0.98),也不因PCOS状态而异(OR 1.27,95%CI 0.91-1.77)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the fertility treatment pathways used by women with and without polycystic ovary syndrome (PCOS) and which pathways were more likely to result in a birth. DESIGN: This retrospective national community-based cohort study used longitudinal self-report survey data (collected 1996-2022; aged 18-49 years) from women born in 1973-1978 who are participants in the Australian Longitudinal Study on Women's Health. The study also used linked administrative data on fertility treatments (1996-2021). PATIENTS: Of the 8,463 eligible women, 1,109 accessed fertility treatment and were included. EXPOSURE: Polycystic ovary syndrome diagnosis was self-reported. MAIN OUTCOME MEASURE: use of ovulation induction (OI), intrauterine insemination, and/or in vitro fertilization (IVF) was established through linked administrative data. Births were self-reported. RESULTS: One in 10 of the eligible participants had PCOS (783/7,987, 10%) and 1 in 4 of the women who used fertility treatment had PCOS (274/1,109, 25%). Women with PCOS were 3 years younger on average at first fertility treatment (M = 31.4 years, SD = 4.18) than women without PCOS (M = 34.2 years, SD = 4.56). Seven treatment pathways were identified and use differed by PCOS status. Women with PCOS were more likely to start with OI (71%; odds ratio [OR] 4.20, 95% confidence interval [CI]: 2.91, 6.07) than women without PCOS (36%). Of the women with PCOS who started with OI, 46% required additional types of treatment. More women without PCOS ended up in IVF (72% vs. 51%). Overall, 63% (701/1,109) had an attributed birth, and in adjusted regressions births did not vary by last type of treatment (IVF: 67%, reference; intrauterine insemination: 67%, OR 0.94 95% CI: 0.56, 1.58; OI: 61%, OR 0.71, 95% CI: 0.52, 0.98), or by PCOS status (OR 1.27, 95% CI: 0.91, 1.77). By age, 74% of women under 35 years (471/639) and 49% of women 35 years or older had a birth. CONCLUSION: More women with PCOS used fertility treatment but births were equivalent to women without PCOS. Most women followed clinical recommendations. Births did not differ between pathways, so there was no disadvantage in starting with less invasive treatments (although there may be financial or emotional disadvantages).
引用
- Moss KM, Doust J, Copp T, et al. Fertility treatment pathways and births for women with and without polycystic ovary syndrome-a retrospective population linked data study. Fertil Steril. 2023. PMID: 38099868. doi:10.1016/j.fertnstert.2023.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。